3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Conditions
Neoplasms
3
Lung Neoplasms
2
Hematopoietic and Lymphatic System Neoplasm
2
Colorectal Neoplasms
2
Smoking Cessation
1
Sedentary Behavior
1
Sarcoma
1
Pyloric Stenosis, Hypertrophic
1
Prostatic Neoplasms
1
Pain
1
Myelodysplastic Syndromes
1
Motor Activity
1
Metastatic Pancreatic Adenocarcinoma
1
Malignant Hepatobiliary Neoplasm
1
Lymphoma, Non-Hodgkin
1
Leukemia, Myeloid, Acute
1
Hodgkin Disease
1
Hematopoietic and Lymphoid System Neoplasm
1
FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma
1
Chronic Pain
1
Chronic Disease
1
Cervical Cancer Screening
1
Carcinoma, Non-Small-Cell Lung
1
Cancer Pain
1
COVID-19
1
Breast Neoplasms
1
Breast Carcinoma In Situ
1
Alzheimer Disease
1
Agnosia
1
Interventions
fludarabine
52
Cyclophosphamide
50
venetoclax
47
Azacitidine
44
fludarabine phosphate
41
Whole-Body Irradiation
33
Specimen Handling
31
Mycophenolic Acid
30
Tacrolimus
28
Melphalan
28
Busulfan
27
Cytarabine
25
Stem Cell Transplantation
23
Decitabine
23
Biopsy
22
Granulocyte Colony-Stimulating Factor
19
Sirolimus
16
Peripheral Blood Stem Cell Transplantation
16
Filgrastim
16
Thiotepa
15
decitabine and cedazuridine drug combination
14
Injections
13
Cyclosporine
13
ruxolitinib
9
Methotrexate
9
Mesna
9
Hematopoietic Stem Cell Transplantation
9
X-Rays
8
Idarubicin
8
Daunorubicin
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Myelodysplastic Syndromes
×
Telemedicine
×
1 year
×
Clear all
NCT04745676
2026-03-31
SICG
University of Rochester
Phase NA
Completed
36 enrolled
16 charts